NCT04576507View on ClinicalTrials.gov

Repeated Cannabis Administration on Experimental Pain and Abuse Liability

PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

CannabisPainToleranceHyperalgesia

Interventions

DRUG

Active Cannabis

2.98% THC:4.91% CBD cannabis.

DRUG

Placebo Cannabis

\<0.01% THC:CBD cannabis.

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Alkermes, Inc.

INDUSTRY

lead

New York State Psychiatric Institute

OTHER

NCT04576507 - Repeated Cannabis Administration on Experimental Pain and Abuse Liability | Biotech Hunter | Biotech Hunter